IODIZED FATTY ACID ESTERS CONTAINING AT LEAST 50 PER CENT OF MONOIODO STEARIC ACID ESTERS OR DERIVATIVES IN THE FORM OF A SOFT CAPSULE OR GELULE, USEFUL IN A NUCLEAR ACCIDENT.

摘要

Iodinated fatty acid esters containing not less than 50 per cent monoiodostearic acid esters of fatty acid esters of rapeseed oil, or derivatives, of pharmaceutical purity, fully iodinated, no longer containing duplicates stable bonds for the preparation of an organism protective product of drug quality either in a pure form in the form of soft capsules, capsules, or in combination with excipients in the form of soft capsule, of capsule for oral administration, useful in a nuclear accident, allowing a prolonged supply of an additional dose of iodine to the thyroid gland and in which the quantity of iodine, administered follows the recommendations of the 'World Health Organization. Thus the use of defined doses for oral administration, stable for 5 years or even 10 years at 25 ° C is recommended, or soft capsule, containing 351 mg of Brassiodol corresponding to the concentration of 100 mg of 127 |, for the child over 12 years old and adult, or soft capsule containing 175 mg of Brassiodol corresponding to the concentration of 50 mg of 127 |, for the child from 36 months to 12 years, or soft capsule containing 88 mg of Brassiodol corresponding to the concentration of 25 mg of 127 |, for the infant from 1 to 36 months. These soft Brassiodol capsules can be used by populations in regions where there is a relative lack of dietary iodine, allowing additional preventive coverage of the thyroid gland for 6 months.